EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease

Shalender Bhasin iD, Venkatesh Krishnan, Thomas W Storer, Mitchell Steiner, Adrian S Dobs

The Journals of Gerontology: Series A · 16.06.2023 · 78 (Supplement_1) · 25-31

DOI: 10.1093/gerona/glad027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journals of Gerontology: Series A, online erschienen am 16.06.2023. Verfasst von Shalender Bhasin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Program in Men's Health: Aging and Metabolism, Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Boston, M…. Hauptthemen laut MEDLINE: Androgens, Anabolic Agents. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINR NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testosterone, many steroidal androgens, and nonsteroidal ligands that bind to androgen receptor and exert tissue-specific transcriptional activity (selective androgen receptor modulators [SARMs]) are being developed as function-promoting therapies to treat functional limitations associated with aging and chronic diseases. This narrative review describes preclinical studies, mechanisms, and randomized trials of testosterone, other androgens, and nonsteroidal SARMs. Sex differences in muscle mass and strength and empiric use of anabolic steroids by athletes to increase muscularity and athletic performance provide supportive evidence of testosterone’s anabolic effects. In randomized trials, testosterone treatment increases lean body mass, muscle strength, leg power, aerobic capacity, and self-reported mobility. These anabolic effects have been reported in healthy men, hypogonadal men, older men with mobility limitation and chronic diseases, menopausal women, and HIV-infected women with weight loss. Testosterone has not consistently improved walking speed. Testosterone treatment increases volumetric and areal bone mineral density, and estimated bone strength; improves sexual desire, erectile function, and sexual activity; modestly improves depressive symptoms; and corrects unexplained anemia in older men with low testosterone levels. Prior studies have not been of sufficient size or duration to determine testosterone’s cardiovascular and prostate safety. The efficacy of testosterone in reducing physical limitations, fractures, falls, progression to diabetes, and correcting late-onset persistent depressive disorder remains to be established. Strategies to translate androgen-induced muscle mass and strength gains into functional improvements are needed. Future studies should evaluate the efficacy of combined administration of testosterone (or a SARM) plus multidimensional functional exercise to induce neuromuscular adaptations required for meaningful functional improvements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AndrogensAnabolic AgentsHumansFemaleMaleAgedReceptors, AndrogenTestosteroneAndrogen AntagonistsChronic DiseaseAging

Stichwörter der Autor:innen

Bone mineral densityDepressive symptomsFunctional exercise trainingTestosterone

Substanzen

AndrogensReceptors, AndrogenAnabolic AgentsTestosteroneAndrogen Antagonists

Autor:innen und Institutionen

  • Research Program in Men's Health: Aging and Metabolism, Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Boston, Massachusetts,USA.
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana,USA.
  • Veru, Miami, Florida,USA.
  • Johns Hopkins Clinical Research Network, Division of Endocrinology, Diabetes and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland,USA.

ORCID-Profile: Shalender Bhasin

Förderung

  • NIA NIH HHS
  • NINR NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Boston Claude D. Pepper Older Americans Independence Center
  • National Institute on Aging

Zitieren

APA

Bhasin, S., Krishnan, V., Storer, T. W., Steiner, M., & Dobs, A. S. (2023). Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease. The Journals of Gerontology: Series A, 78(Supplement_1), 25-31. https://doi.org/10.1093/gerona/glad027

Vancouver

Bhasin S, Krishnan V, Storer TW, Steiner M, Dobs AS. Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease. The Journals of Gerontology: Series A. 2023;78(Supplement_1):25-31. doi:10.1093/gerona/glad027

BibTeX
@article{Bhasin2023,
  author = {Bhasin, Shalender and Krishnan, Venkatesh and Storer, Thomas W and Steiner, Mitchell and Dobs, Adrian S},
  title = {Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease},
  journal = {The Journals of Gerontology: Series A},
  year = {2023},
  volume = {78},
  number = {Supplement_1},
  pages = {25--31},
  doi = {10.1093/gerona/glad027}
}
Kostenlos starten →